Odyssey Therapeutics Inc
NASDAQ:ODTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Odyssey Therapeutics Inc
NASDAQ:ODTX
|
US |
|
K
|
KB No.29 Special Purpose Acquisition Co
KOSDAQ:478390
|
KR |
|
Carlo Gavazzi Holding AG
SIX:GAV
|
CH |
|
M
|
Mandrake Resources Ltd
ASX:MAN
|
AU |
|
Razor Energy Corp
XTSX:RZE
|
CA |
|
Rand Capital Corp
NASDAQ:RAND
|
US |
|
A
|
Amoeba SA
F:A1H
|
FR |
|
H
|
HizeAero Co Ltd
KOSDAQ:221840
|
KR |
|
T
|
Tusnad SA
XBSE:TSND
|
RO |
|
American Rebel Holdings Inc
OTC:AREB
|
US |
|
PolyPlank AB (publ)
F:PP7
|
SE |
|
A
|
Afentra PLC
XBER:TB8A
|
UK |
Wall St Price Targets
ODTX Price Targets Summary
Odyssey Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for ODTX is 35.7 USD with a low forecast of 30.3 USD and a high forecast of 42 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ODTX's stock price target?
Price Target
35.7
USD
According to Wall Street analysts, the average 1-year price target for ODTX is 35.7 USD with a low forecast of 30.3 USD and a high forecast of 42 USD.
What is the Revenue forecast for Odyssey Therapeutics Inc?
Projected CAGR
67%
Over the last 1 year, the compound annual growth rate for Revenue has been -33%. The projected CAGR for the next 8 years is 67%.